Search research articles
Contact Us
Filters
Showing results (101-110 of 158) with videos related to
Page
of 16
Sort By:
Brain Sciences
|
April 9, 2020
Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome
Marika C Coffman, Rebecca C Shaffer, Lauren M Schmitt, et al.
Psychopharmacology
|
February 26, 2013
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
Craig A Erickson, Logan K Wink, Balmiki Ray, et al.
Research in Developmental Disabilities
|
July 28, 2017
Eye gaze and pupillary response in Angelman syndrome
Michael P Hong, Janna L Guilfoyle, Lindsey N Mooney, et al.
Scientific Reports
|
October 3, 2024
Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome
Lauren E Ethridge, Ernest V Pedapati, Lauren M Schmitt, et al.
Frontiers in Behavioral Neuroscience
|
January 23, 2023
Parallel learning and cognitive flexibility impairments between <i>Fmr1</i> knockout mice and individuals with fragile X syndrome
Lauren M Schmitt, Anna L Arzuaga, Ashley Dapore, et al.
Journal of Neurodevelopmental Disorders
|
January 23, 2019
Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study
Michael P Hong, Eleanor M Eckert, Ernest V Pedapati, et al.
Journal of Psychiatric Research
|
October 11, 2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker
Craig A Erickson, Balmiki Ray, Bryan Maloney, et al.
Journal of Autism and Developmental Disorders
|
July 10, 2020
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study
Logan K Wink, Debra L Reisinger, Paul Horn, et al.
Journal of Autism and Developmental Disorders
|
April 13, 2018
A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder
Logan K Wink, Ryan Adams, Paul S Horn, et al.
Scientific Reports
|
April 1, 2026
Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome
Lisa A De Stefano, Hyeonseok Kim, Craig A Erickson, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 158) with videos related to
Sort By:
Page
of 16
Brain Sciences
|
April 9, 2020
Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome
Marika C Coffman, Rebecca C Shaffer, Lauren M Schmitt, et al.
Psychopharmacology
|
February 26, 2013
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
Craig A Erickson, Logan K Wink, Balmiki Ray, et al.
Research in Developmental Disabilities
|
July 28, 2017
Eye gaze and pupillary response in Angelman syndrome
Michael P Hong, Janna L Guilfoyle, Lindsey N Mooney, et al.
Scientific Reports
|
October 3, 2024
Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome
Lauren E Ethridge, Ernest V Pedapati, Lauren M Schmitt, et al.
Frontiers in Behavioral Neuroscience
|
January 23, 2023
Parallel learning and cognitive flexibility impairments between <i>Fmr1</i> knockout mice and individuals with fragile X syndrome
Lauren M Schmitt, Anna L Arzuaga, Ashley Dapore, et al.
Journal of Neurodevelopmental Disorders
|
January 23, 2019
Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study
Michael P Hong, Eleanor M Eckert, Ernest V Pedapati, et al.
Journal of Psychiatric Research
|
October 11, 2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker
Craig A Erickson, Balmiki Ray, Bryan Maloney, et al.
Journal of Autism and Developmental Disorders
|
July 10, 2020
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study
Logan K Wink, Debra L Reisinger, Paul Horn, et al.
Journal of Autism and Developmental Disorders
|
April 13, 2018
A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder
Logan K Wink, Ryan Adams, Paul S Horn, et al.
Scientific Reports
|
April 1, 2026
Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome
Lisa A De Stefano, Hyeonseok Kim, Craig A Erickson, et al.
Page
of 16